Effect of different methods for estimating persistence and adherence to new glucose-lowering drugs: results of an observational, inception cohort study in Portugal

References

• StrattonIMAssociation of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ2000321725840541210938048
   PubMed Web of Science ®Google Scholar
• TurnerRCMillnsHNeilHAWRisk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)Br Med J199831671348238289549452
   PubMed Web of Science ®Google Scholar
• CampbellPTNewtonCCPatelAVJacobsEJGapsturSMDiabetes and cause-specific mortality in a prospective cohort of one million U.S. adultsDiabetes Care20123591835184422699290
   PubMed Web of Science ®Google Scholar
• ChoNHShawJEKarurangaSIDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045Diabetes Res Clin Pract201813827128129496507
   PubMed Web of Science ®Google Scholar
• PereiraMCarreiraHLunetNAzevedoATrends in prevalence of diabetes mellitus and mean fasting glucose in Portugal (1987–2009): a systematic reviewPublic Health2014128321422124559769
   PubMed Web of Science ®Google Scholar
• IDFIDF Diabetes AtlasBrusselsIDF2015
   Google Scholar
• InzucchiSEBergenstalRMBuseJBManagement of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care201538114014925538310
   PubMed Web of Science ®Google Scholar
• Direcção-Geral da Saúde/Ministério da SaúdeAbordagem Terapêutica Farmacológica na Diabetes Mellitus Tipo 2 no Adulto [Pharmacological approach to type 2 diabetes mellitus in adults]Norma da Direção-Geral da Saúde2015 Portuguese
   Google Scholar
• BoyeKSCurtisSELageMJGarcia-PerezLEAssociations between adherence and outcomes among older, type 2 diabetes patients: evidence from a Medicare Supplemental databasePatient Prefer Adherence2016101573158127574406
   PubMed Web of Science ®Google Scholar
• CurrieCJPeyrotMMorganCLThe impact of treatment noncompliance on mortality in people with type 2 diabetesDiabetes Care20123561279128422511257
   PubMed Web of Science ®Google Scholar
• García-PérezL-EÁlvarezMDillaTGil-GuillénVOrozco-BeltránDAdherence to therapies in patients with type 2 diabetesDiabetes Ther20134217519423990497
   PubMed Web of Science ®Google Scholar
• PratleyREThe efficacy and effectiveness of drugs for diabetes: how do clinical trials and the real world compare?Diabetologia20145771273127524849569
   PubMed Web of Science ®Google Scholar
• SuissaSMoodieEEMDell’AnielloSPrevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scoresPharmacoepidemiol Drug Saf201726445946827610604
   PubMed Web of Science ®Google Scholar
• PawaskarMBonafedeMJohnsonBFowlerRLenhartGHoogwerfBMedication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database studyBMC Endocr Disord2013132023799930
   PubMed Web of Science ®Google Scholar
• KarveSClevesMAHelmMHudsonTJWestDSMartinBCAn empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patientsMed Care200846111125113318953222
   PubMed Web of Science ®Google Scholar
• OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
   PubMed Web of Science ®Google Scholar
• ChoudhryNKShrankWHLevinRLMeasuring concurrent adherence to multiple related medicationsAm J Manag Care200915745746419589013
   PubMed Web of Science ®Google Scholar
• RousselRCharbonnelBBeharMGourmelenJEmeryCDetournayBPersistence with insulin therapy in patients with type 2 diabetes in France: an insurance claims studyDiabetes Ther20167353754927421274
   PubMed Web of Science ®Google Scholar
• GrabnerMPengXGeremakisCBaeJDemographic and clinical profiles of type 2 diabetes mellitus patients initiating canagliflozin versus DPP-4 inhibitors in a large U.S. managed care populationJ Manag Care Spec Pharm201521121204121226679969
   PubMed Web of Science ®Google Scholar
• SuissaSGarbeEPrimer: administrative health databases in observational studies of drug effects – advantages and disadvantagesNat Clin Pract Rheumatol200731272573218037932
   PubMedGoogle Scholar
• TorreCMartinsAOverview of pharmacoepidemiological databases in the assessment of medicines under real-life conditionsCurrent Perspectives on Research and PracticeIn Tech Nuno LunetCroatia2012131154
   Google Scholar
• ParkBJStergachisAAutomated databases in pharmacoepidemiologic studiesPharmacoepidemiology and Therapeutic ManagementCincinnati, OHHarvey Whitney Books2008
   Google Scholar
• ChoudhryNKPromoting persistence improving adherence through choice of drug classCirculation2011123151584158721464048
   PubMed Web of Science ®Google Scholar
• TorreCGuerreiroJDe Oliveira MartinsSRaposoJFMartinsAPLeufkensHPatterns of glucose lowering drugs utilization in Portugal and in the Netherlands. Trends over timePrim Care Diabetes20159648248925911273
   PubMed Web of Science ®Google Scholar
• VinkNMKlungelOHStolkRPDenigPComparison of various measures for assessing medication refill adherence using prescription dataPharmacoepidemiol Drug Saf20091815916519109809
   PubMed Web of Science ®Google Scholar
• KarveSClevesMAHelmMHudsonTJGood and poor adherence: optimal cut-point for adherence measures using administrative claims dataCurr Med Res Opin20092592303231019635045
   PubMed Web of Science ®Google Scholar
• IglayKCartierSERosenVMMeta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetesCurr Med Res Opin20153171283129626023805
   PubMed Web of Science ®Google Scholar
• KrassISchiebackPDhippayomTAdherence to diabetes medication: a systematic reviewDiabet Med201532672573725440507
   PubMed Web of Science ®Google Scholar
• BalkrishnanRPredictors of medication adherence in the elderlyClin Ther19982047647719737835
   PubMed Web of Science ®Google Scholar
• KimHKimHSBowmanJDChoNHComparing diabetic patient characteristics related to stated medication adherence in a rural vs. urban community in KoreaJ Clin Pharm Ther2016411404626714628
   PubMed Web of Science ®Google Scholar
• GuénetteLMoisanJBretonMCSiroisCGrégoireJPDifficulty adhering to antidiabetic treatment: factors associated with persistence and complianceDiabetes Metab201339325025723523643
   PubMed Web of Science ®Google Scholar
• CaiJWangYBaserOXieLChowWComparative persistence and adherence with newer anti-hyperglycemic agents to treat patients with type 2 diabetes in the United StatesJ Med Econ201619121175118627356271
   PubMed Web of Science ®Google Scholar
• CaiJDivinoVBurudpakdeeCAdherence and persistence in patients with type 2 diabetes mellitus newly initiating canagliflozin, dapagliflozin, dpp-4s, or glp-1s in the United StatesCurr Med Res Opin20173371317132828418262
   PubMed Web of Science ®Google Scholar
• LaranjoLRodriguesDPereiraAMRibeiroRTBoavidaJMUse of electronic health records and geographic information systems in public health surveillance of type 2 diabetes: a feasibility studyJMIR Public Health Surveill201621e1227227147
   PubMedGoogle Scholar
• CongetIMauricioDOrtegaRDetournayBCharacteristics of patients with type 2 diabetes mellitus newly treated with GLP-1 receptor agonists (CHADIG Study): a cross-sectional multicentre study in SpainBMJ Open201667e010197
   Web of Science ®Google Scholar
• FonsecaVADefining and characterizing the progression of type 2 diabetesDiabetes Care200932Suppl 2S151S15619875543
   PubMed Web of Science ®Google Scholar
• DossaARGrégoireJPLauzierSGuénetteLSiroisCMoisanJAssociation between loyalty to community pharmacy and medication persistence and compliance, and the use of guidelines-recommended drugs in type 2 diabetesMedicine (Baltimore)20159427e108226166087
   PubMed Web of Science ®Google Scholar
• ZongoFEMoisanJGrégoireJ-PLesageADossaARLauzierSAssociation between community pharmacy loyalty and persistence and implementation of antipsychotic treatment among individuals with schizophreniaRes Soc Adm Pharm20161415361
   Web of Science ®Google Scholar
• ChoudhryNKFischerMAAvornJThe implications of therapeutic complexity on adherence to cardiovascular medicationsArch Intern Med2011171981482221555659
   PubMedGoogle Scholar
• MarcumZADriessenJThorpeCTGelladWFDonohueJMEffect of multiple pharmacy use on medication adherence and drug–drug interactions in older adults with medicare part DJ Am Geriatr Soc201462224425224521363
   PubMed Web of Science ®Google Scholar
• HakobyanLHaaijer-RuskampFMde ZeeuwDDobreDDenigPA review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patientsHealth Qual Life Outcomes201198321958008
   PubMed Web of Science ®Google Scholar
• GlintborgBHillestrømPRHolm OlsenLDalhoffKPEnghusen PoulsenHAre patients reliable when self-reporting medication use? Validation of structured drug interviews and home visits by drug analysis and prescription data in acutely hospitalized patientsJ Clin Pharmacol200747111440144917962430
   PubMed Web of Science ®Google Scholar
• GarfieldSCliffordSEliassonLBarberNWillsonASuitability of measures of self-reported medication adherence for routine clinical use: a systematic reviewBMC Med Res Methodol201111114922050830
   PubMed Web of Science ®Google Scholar
• KaplanRMSimonHJCompliance in medical care: reconsideration of self-predictionsAnn Behav Med19901226671
   Google Scholar
• FischerMAStedmanMRLiiJPrimary medication non-adherence: analysis of 195,930 electronic prescriptionsJ Gen Intern Med201025428429020131023
   PubMed Web of Science ®Google Scholar
• da CostaFAPedroARTeixeiraIBragançaFda SilvaJACabritaJPrimary non-adherence in Portugal: findings and implicationsInt J Clin Pharm201537462663525832675
   PubMed Web of Science ®Google Scholar
• KalsekarISheehanCPeakAUtilization patterns and medication adherence in patients with type 2 diabetes: variations based on type of pharmacy (chain vs independent)Res Soc Adm Pharm200734378391
   PubMedGoogle Scholar